Chung, Y., Ha, K. H., Kim, H. C., Park, S. J., Lee, K., & Kim, D. J. (2019). Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study. Diabetes Metab J.
Styl ChicagoChung, Yoo-Ri, Kyoung Hwa Ha, Hyeon Chang Kim, Sang Jun Park, Kihwang Lee, a Dae Jung Kim. "Dipeptidyl Peptidase-4 Inhibitors Versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study." Diabetes Metab J 2019.
Citace podle MLAChung, Yoo-Ri, et al. "Dipeptidyl Peptidase-4 Inhibitors Versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study." Diabetes Metab J 2019.